Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Overview of attention for article published in Trials, June 2020

Altmetric Badge

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 329 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,040 followers.

RT @ASIPath: #ASIPWebinar Clinical Trial Design: https://t.co/AAEURtA7iX

29 Sep 2020

Reply Repost Favourite

#ASIPWebinar Clinical Trial Design: https://t.co/AAEURtA7iX

29 Sep 2020

Reply Repost Favourite

@ISPM_ZOAP Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. https://t.co/K82g4J6NfZ

10 Jun 2020

Reply Repost Favourite